Clinical Trials Logo

Clinical Trial Summary

The main purpose of the study is to evaluate in a prospective cohort of patients with an appointment for the performance of an outpatient colonoscopy the prediction of the quality of colonic cleansing through the use of 3 predictive models. The colon cleansing quality will be assessed by a validated scale (Boston Bowel Preparation Scale, BBPS). Patients will be prepared with polyethylene glycol (PEG), PEG plus ascorbic acid (PEG-Asc) or sodium picosulfate-oxide magnesium solution (PS).


Clinical Trial Description

Although, current guidelines recommend a rate of inadequate bowel cleansing for colonoscopy not higher than 10-15%, in clinical practice poor bowel cleansing in endoscopy units ranged between 6.8% and 33%. The determinants of poor cleanliness have been evaluated in different studies and can be classified into patient-dependent predictors, which include demographic, socioeconomic and clinical variables, variables dependent on the preparation protocol, including the assigned diet, the type of preparation, its fractionation and the space of time elapsed between the last intake and the colonoscopy, and the tolerance mainly attributed to the volume and taste of the evacuating preparation The American Association of Gastrointestinal Endoscopy recommends the administration of additional preparation to these patients with a higher probability of inadequate preparation. Once non-compliance and lack of tolerance to cleaning protocols are excluded, the reason for inadequate preparation is usually the lack of effectiveness of the cleaning protocol. Therefore, it is advisable to select patients who can benefit from supplemented cleaning preparation or intensified cleaning protocols. There are so far 4 published predictive models that incorporate clinical variables with the aim of determining patients who are candidates for intensified preparations. Of the models mentioned in the previous studies, only 3 are clearly detailed in the corresponding articles. The researchers will offer to participate in the study to patients scheduled for a colonoscopy who meet all the inclusion criteria and none of the exclusion criteria. The researchers will explain the purpose of the study and will ask to sign the informed consent. They will give verbal and written information. Subsequently, the colonoscopy will be performed and the cleaning quality will be scored according to the BBPS considering suboptimal a cleaning quality of less than 2 points in a segment of the colon. The bowel cleansing quality following BBPS will be assessed by the endoscopist ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05871801
Study type Observational
Source University of La Laguna
Contact Antonio Z Gimeno García, MD, PhD
Phone +34922678554
Email antozeben@gmail.com
Status Recruiting
Phase
Start date May 20, 2023
Completion date September 1, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05553977 - Artificial Intelligence and Bowel Cleansing Quality
Not yet recruiting NCT05871814 - Artificial Intelligence and Bowel Cleansing Quality N/A
Completed NCT03830489 - Impact of a Predictive Score of Bowel Preparation Quality in Clinical Practice Phase 4
Completed NCT04702646 - Patient and Colonoscopy Cleansing Quality Agreement
Completed NCT03247452 - Impact of Low Fiber Diet on Colonic Cleansing Quality (DIETPREP) N/A